Enrolling by invitation
Not applicable
Clinical Study of Rhythmic Auditory Stimulation for Gait Disorders
Condition(s) studied
Hemiplegia Due to StrokeParkinson DiseaseParkinsonian Syndrome
Investigational drug(s) / intervention(s)
rhythmic auditory stimulationNo rhythm stimulation
rhythmic auditory stimulation: The intervention group was treated with a gait rhythm device under the supervision of the researchers. The complete gait training was conducted once a day for 15 minutes for 7 consecutive days. Each patient wore inertial sensors at both ankles during gait training to collect gait information during walking.
No rhythm stimulation: The control group received gait training without rhythmic auditory stimulation under the supervision of the researchers. The complete gait training was conducted once a day for 15 to 20 minutes for 7 consecutive days. Each patient wore inertial sensors at both ankles during gait training to collect gait information during walking.
Study summary
The aim of this clinical trial was to determine whether rhythmic auditory stimulation is effective in treating gait disorders in patients with post-stroke hemiplegia, primary Parkinson's disease, and various parkinsonism syndromes. The main questions it aims to answer are:
Does rhythmic auditory stimulation increase walking speed in patients with gait disorders? To determine whether rhythmic auditory stimulation is effective in treating gait disorders, researchers will compare a gait rhythmometer with an active control that does not receive rhythmic stimulation.
Participants will:
Gait training was conducted once a day for 15 minutes for 7 consecutive days Resting-state functional magnetic resonance imaging (fmri) was performed before and after treatment Feedback on subjective improvement at the end of the 7-day treatment
Eligibility
For post-stroke hemiplegia
Inclusion criteria :
* Age 50-80 years old
* One or more strokes (cerebral infarction or cerebral hemorrhage), with the most recent stroke occurring at least 6 months earlier
* Walking independently without a cane or walking aid with obvious gait asymmetry
* 0.4m/s\< baseline velocity \<0.8m/s
* Sufficient hearing, vision and comprehension to complete motor function tests
* Patients were willing and able to participate in all study procedures and signed informed consent
* No other rehabilitation treatment was received at present
Exclusion Criteria:
* Unable to cooperate with the motor function test
* Uncontrolled hypertension
* Myocardial infarction within the past 3 months
* With bone and joint diseases, such as a history of lower limb fracture within 1 year, waist and lower limb bone and joint surgery, bone and joint deformity seriously affecting walking, etc.
* Except for stroke, there was no parkinsonism, myasthenia gravis, poliomyelitis and other nervous system diseases affecting the walking function of patients.
For primary Parkinson's disease (PD)
Inclusion criteria:
* Age 50-80 years old
* PD met the diagnostic criteria of Chinese Diagnostic Criteria for Parkinson's Disease (2016 edition)
* Obvious panic gait, freezing gait or slow gait, but can walk independently without the use of a cane or walking aid
* Hoehn-Yahr (H-Y) stage 2-4
* 0.4m/s\< baseline velocity \<0.8m/s
* Sufficient hearing, vision and comprehension to complete motor function tests
* Patients were willing and able to participate in all study procedures and signed informed consent
* No other rehabilitation treatment was received at present
Exclusion criteria:
* Unable to cooperate with the motor function test
* Uncontrolled hypertension
* Myocardial infarction within the past 3 months
* With bone and joint diseases, such as a history of lower limb fracture within 1 year, waist and lower limb bone and joint surgery, bone and joint deformity seriously affecting walking, etc
* There was no stroke, myasthenia gravis, poliomyelitis and other neurological diseases affecting the walking function except for primary Parkinson's disease
For Parkinsonism syndrome:
Inclusion criteria:
* Age 50-80 years old
* All parkinsonism syndrome except primary Parkinson's disease, including but not limited to drug-induced parkinsonism, multiple system atrophy, cerebral small vessel disease-related parkinsonism, etc
* obvious panic gait, freezing gait or slow gait, but can walk independently without the use of a cane or walking aid
* 0.4m/s\< baseline velocity \<0.8m/s
* Sufficient hearing, vision and comprehension to complete motor function tests
* Be willing and able to participate in all study procedures and sign informed consent
* No other rehabilitation treatment was received at present.
Exclusion criteria:
* Unable to cooperate with the motor function test
* Uncontrolled hypertension
* Myocardial infarction within the past 3 months
* With bone and joint diseases, such as a history of lower limb fracture within 1 year, waist and lower limb bone and joint surgery, bone and joint deformity seriously affecting walking, etc
* There was no stroke, myasthenia gravis, poliomyelitis and other neurological diseases that affected the walking function except for parkinsonism
Primary outcome measure(s)
- Gait speed — 10 days
The difference between the gait speed measured on the third day after the completion of the seven gait sessions and the baseline gait speed
Trial sites (1)
| Facility | City | Region | Status |
|---|
| Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College |
Beijing |
Beijing Municipality |
|
Other trials for the same condition